Human medicines

Oncaspar solution for injection

Medicines | 19/11/2013

The company responsible for distribution, sigma-tau ArzneimittelGmbH, 40212 Düsseldorf, Germany, informed its supplied customers on November 15, 2013,…

Oncaspar solution for injection Read more

Oncaspar

Recall | Medicines | 12/11/2013

Due to a possible quality defect, the companies Sigma-Tau Arzneimittel GmbH and Sigma-Tau Rare Diseases S.A. have decided to recall the above…

Oncaspar Read more

Jext solution for injection

Recall | Medicines | 11/11/2013

Due to a technical defect, there is a possibility in a small number of Jext epinephrine auto-injectors that the epinephrine is not correctly applied…

Jext solution for injection Read more

Jext

Recall | Medicines | 08/11/2013

In a small number (0.04% corresponds to 4/10,000) of Jext® pre-filled pens, the adrenaline injection may not be carried out in case of need due to a…

Jext Read more

NovoMix

Replacement | Medicines | 25/10/2013

Due to a manufacturing problem during the filling of the cartridges, individual products of the above mentioned batches of "NovoMix® 30 FLexPen®" may…

NovoMix Read more

Lovenox Pen

Recall | Medicines | 14/10/2013

The marketing authorization holder has informed its supplied customers in a letter dated 11.10.2013 that complaints have arisen describing the…

Lovenox Pen Read more

Tardocillin

Recall | Medicines | 09/10/2013

On October 8, 2013, the marketing authorization holder informed its customers that injection vials may have an externally invisible defect under the…

Tardocillin Read more

Denosumab (investigational product)

Replacement | Medicines | 02/10/2013

During a routine quality check, a small number of prefilled syringes were found to contain particles consisting mainly of cellulose fibers. The…

Denosumab (investigational product) Read more

Dancor

Recall | Medicines | 17/09/2013

The marketing authorization holder has informed its supplied customers in a letter dated 13.09.2013 that investigations have shown that the optimal…

Dancor Read more

Soliris

Replacement | Medicines | 22/08/2013

The marketing authorization holder informed its supplied customers in a letter dated August 22, 2013, that visible particles were detected in some…

Soliris Read more
Email

Further inquiry note